Intensive Systolic BP Target Cost-Effective for Patients at High Cardiovascular Risk

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 19, 2025.

via HealthDay

TUESDAY, Aug. 19, 2025 -- For patients 50 years or older at high cardiovascular risk without diabetes or prior stroke, an intensive systolic blood pressure (SBP) target (<120 mm Hg) seems cost-effective at most settings with measurement error, according to a study published online Aug. 19 in the Annals of Internal Medicine.

Karen C. Smith, Ph.D., from Brigham and Women's Hospital in Boston, and colleagues used data from the National Health and Nutrition Examination Survey to generate a simulated cohort of adults at high cardiovascular risk who met Systolic Blood Pressure Intervention Trial inclusion criteria and examined the effect of measurement error on the cost-effectiveness of intensive SBP targets. Incremental cost-effectiveness ratios (ICERs) were compared for SBP targets of less than 120, 130, and 140 mm Hg.

The researchers found that the ICER for the target of less than 120 versus less than 130 mm Hg was $24,400 per quality-adjusted life-year (QALY) with research-grade SBP measurement (mean error, 0 mm Hg) in the base-case analysis. The ICER increased to $42,000 per QALY with average measurement error (mean error, 7.3 mm Hg in the <120-mm Hg target). In sensitivity analyses, in scenarios with high error (mean error ≥14.6 mm Hg in the <120-mm Hg target), the ICER for the target of less than 120 mm Hg was greater than $100,000 per QALY, when an inflection point for increasing risk for cardiovascular disease was at or above 116 mm Hg and in scenarios with a medication-taking disutility of at least 0.003 per antihypertensive medication.

"This study should give patients at high cardiovascular risk and their clinicians more confidence in pursuing an intensive blood pressure goal," Smith said in a statement. "Our findings suggest the intensive <120 mm Hg target prevents more cardiovascular events and provides good value, and this holds true even when measurements aren't perfect."

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-08-20 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords